Synthetic BiologybioRxivPreprint
A Saccharomyces boulardii synthetic biotic platform for delivery of therapeutic nanobodies to ameliorate gastrointestinal inflammation
Roger Palou, Almer M. van der Sloot, Aline Fiebig‐Comyn…·Mike Tyers
This paper develops a Saccharomyces boulardii platform for producing and delivering therapeutic nanobodies to treat gastrointestinal inflammation in mice.
DOI 10.1101/2025.05.15.652971